PRRX1
Basic information
Region (hg38): 1:170662728-170739421
Previous symbols: [ "PMX1" ]
Links
Phenotypes
GenCC
Source:
- agnathia-otocephaly complex (Supportive), mode of inheritance: AD
- agnathia-otocephaly complex (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Agnathia-otocephaly complex | AD/AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Audiologic/Otolaryngologic; Craniofacial | 12244557; 21294718; 22211708; 23444262 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PRRX1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 12 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 9 | 7 | 2 |
Variants in PRRX1
This is a list of pathogenic ClinVar variants found in the PRRX1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-170664233-C-T | PRRX1-related disorder | Likely benign (Nov 22, 2023) | ||
1-170664249-C-T | Inborn genetic diseases | Uncertain significance (Dec 27, 2023) | ||
1-170664267-G-A | Inborn genetic diseases | Uncertain significance (Aug 02, 2023) | ||
1-170664307-C-A | Inborn genetic diseases | Uncertain significance (Nov 07, 2024) | ||
1-170664360-A-C | not specified | Uncertain significance (May 28, 2024) | ||
1-170664360-A-T | Inborn genetic diseases | Uncertain significance (Aug 21, 2023) | ||
1-170664362-G-A | Inborn genetic diseases | Uncertain significance (Apr 26, 2024) | ||
1-170664369-G-T | PRRX1-related disorder | Uncertain significance (Mar 05, 2024) | ||
1-170664403-G-A | Benign (Dec 31, 2019) | |||
1-170664419-G-T | Likely benign (Dec 04, 2017) | |||
1-170664428-C-T | Likely benign (Dec 31, 2019) | |||
1-170719746-GA-G | Agnathia-otocephaly complex | Pathogenic (Sep 01, 2012) | ||
1-170719746-G-GAAAA | Agnathia-otocephaly complex | Pathogenic (Apr 01, 2013) | ||
1-170719794-A-G | Benign (Dec 31, 2019) | |||
1-170719801-T-C | Agnathia-otocephaly complex | Likely pathogenic (Sep 01, 2020) | ||
1-170719822-T-C | Agnathia-otocephaly complex | Pathogenic (Mar 01, 2011) | ||
1-170719827-C-T | Agnathia-otocephaly complex | Uncertain significance (Aug 07, 2018) | ||
1-170719908-C-G | PRRX1-related disorder | Benign (Dec 31, 2019) | ||
1-170726219-G-A | Craniosynostosis syndrome | Uncertain significance (Oct 09, 2024) | ||
1-170726270-G-A | Inborn genetic diseases | Uncertain significance (Oct 26, 2021) | ||
1-170726274-G-A | Inborn genetic diseases | Uncertain significance (Jul 27, 2022) | ||
1-170726294-C-G | PRRX1-related disorder | Likely benign (Feb 28, 2019) | ||
1-170726302-C-G | Inborn genetic diseases | Uncertain significance (Dec 10, 2024) | ||
1-170726331-C-G | PRRX1-related disorder | Uncertain significance (Feb 14, 2023) | ||
1-170726337-A-G | Inborn genetic diseases | Uncertain significance (Aug 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PRRX1 | protein_coding | protein_coding | ENST00000239461 | 4 | 76692 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.243 | 0.751 | 125744 | 0 | 4 | 125748 | 0.0000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.02 | 114 | 149 | 0.764 | 0.00000845 | 1581 |
Missense in Polyphen | 54 | 72.41 | 0.74575 | 768 | ||
Synonymous | -1.61 | 79 | 62.7 | 1.26 | 0.00000358 | 498 |
Loss of Function | 2.37 | 3 | 11.8 | 0.255 | 7.53e-7 | 114 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000906 | 0.0000905 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000465 | 0.0000462 |
European (Non-Finnish) | 0.00000880 | 0.00000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a transcriptional regulator of muscle creatine kinase (MCK) and so has a role in the establishment of diverse mesodermal muscle types. The protein binds to an A/T-rich element in the muscle creatine enhancer (By similarity). {ECO:0000250}.;
- Disease
- DISEASE: Agnathia-otocephaly complex (AGOTC) [MIM:202650]: A rare condition characterized by mandibular hypoplasia or agnathia, ventromedial auricular malposition (melotia) and/or auricular fusion (synotia), and microstomia with oroglossal hypoplasia or aglossia. Holoprosencephaly is the most commonly identified association, but skeletal, genitourinary, and cardiovascular anomalies, and situs inversus have been reported. The disorder is almost always lethal. {ECO:0000269|PubMed:21294718}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.203
Intolerance Scores
- loftool
- 0.0691
- rvis_EVS
- 0.28
- rvis_percentile_EVS
- 71.27
Haploinsufficiency Scores
- pHI
- 0.856
- hipred
- Y
- hipred_score
- 0.837
- ghis
- 0.551
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.781
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Prrx1
- Phenotype
- craniofacial phenotype; homeostasis/metabolism phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; skeleton phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype;
Zebrafish Information Network
- Gene name
- prrx1a
- Affected structure
- atrium
- Phenotype tag
- abnormal
- Phenotype quality
- decreased size
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;positive regulation of mesenchymal cell proliferation;embryonic limb morphogenesis;inner ear morphogenesis;middle ear morphogenesis;positive regulation of smoothened signaling pathway;positive regulation of transcription by RNA polymerase II;neuron fate determination;embryonic cranial skeleton morphogenesis;artery morphogenesis;cartilage development;roof of mouth development;regulation of neuron projection regeneration;neuronal stem cell population maintenance
- Cellular component
- nucleoplasm;cytosol
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;transcription coactivator activity;HMG box domain binding